ArQule, Inc. (ARQL) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE WALL STREET
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2019
MRQ
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 99,558,00048,036,00031,126,00038,772,00059,208,00074,695,000
Cash and cash equivalents 19,236,00020,229,00015,267,00013,983,00012,525,00015,579,000
Short-term investments 80,322,00027,807,00015,859,00024,789,00046,683,00059,116,000
Receivables 5,984,000     
Prepaid expense 861,000     
Other undisclosed current assets  547,000822,000714,0001,893,000941,000
Total current assets: 106,403,00048,583,00031,948,00039,486,00061,101,00075,636,000
Noncurrent Assets
Property, plant and equipment 69,000115,000180,000266,000133,0001,128,000
Long-term investments and receivables     4,158,00020,391,000
Long-term investments     4,158,00020,391,000
Deposits noncurrent assets     102,000669,000
Other noncurrent assets 204,000204,000252,000252,000102,0001,024,000
Other undisclosed noncurrent assets     (2,202,000)(669,000)
Total noncurrent assets: 273,000319,000432,000518,0002,293,00022,543,000
TOTAL ASSETS: 106,676,00048,902,00032,380,00040,004,00063,394,00098,179,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 12,948,0008,259,0008,700,0006,234,0006,947,0008,470,000
Employee-related liabilities 1,971,0001,448,0001,856,0001,956,0002,130,000 
Accounts payable 1,329,000537,000710,000186,000259,000146,000
Accrued liabilities 1,151,000865,000673,000819,000805,000 
Other undisclosed accounts payable and accrued liabilities 8,497,0005,409,0005,461,0003,273,0003,753,0008,324,000
Debt 1,667,000    1,700,000
Deferred revenue and credits1,500,000 4,591,00011,098,00011,031,000
Other undisclosed current liabilities     232,000552,000
Total current liabilities: 14,615,0009,759,0008,700,00010,825,00018,277,00021,753,000
Noncurrent Liabilities
Long-term debt and lease obligation 13,093,00014,607,000    
Long-term debt, excluding current maturities 13,093,00014,607,000    
Liabilities, other than long-term debt  1,512,000  4,572,00015,568,000
Deferred revenue and credits   4,572,00015,568,000
Derivative instruments and hedges, liabilities  1,512,000    
Other undisclosed noncurrent liabilities      232,000
Total noncurrent liabilities: 13,093,00016,119,000  4,572,00015,800,000
Total liabilities: 27,708,00025,878,0008,700,00010,825,00022,849,00037,553,000
Temporary equity, carrying amount  8,843,000    
Equity
Equity, attributable to parent 78,968,00014,181,00023,680,00029,179,00040,545,00060,626,000
Common stock 1,090,000871,000711,000629,000628,000627,000
Additional paid in capital 625,993,000547,364,000527,802,000510,664,000508,270,000504,884,000
Accumulated other comprehensive income (loss) (95,000)(16,000)2,0003,000(10,000)67,000
Accumulated deficit (548,020,000)(534,038,000)(504,835,000)(482,117,000)(468,343,000)(444,952,000)
Total equity: 78,968,00014,181,00023,680,00029,179,00040,545,00060,626,000
TOTAL LIABILITIES AND EQUITY: 106,676,00048,902,00032,380,00040,004,00063,394,00098,179,000

Income Statement (P&L) (USD)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:     (1,207,000)(228,000)
Operating expenses (39,463,000)(27,019,000)(27,605,000)(25,391,000)(34,317,000)(40,813,000)
Other undisclosed operating income 25,764,000 4,709,00011,239,00011,254,00015,914,000
Operating loss: (13,699,000)(27,019,000)(22,896,000)(14,152,000)(24,270,000)(25,127,000)
Nonoperating income (expense) (1,552,000)(902,000)178,000378,000914,000559,000
Investment income, nonoperating 1,435,000238,000178,000101,000272,000502,000
Other nonoperating income 1,552,000902,000 277,000642,00057,000
Interest and debt expense (1,666,000)(1,520,000)  (35,000)(32,000)
Loss from continuing operations before equity method investments, income taxes: (16,917,000)(29,441,000)(22,718,000)(13,774,000)(23,391,000)(24,600,000)
Other undisclosed income from continuing operations before income taxes 1,435,000238,000    
Loss from continuing operations: (15,482,000)(29,203,000)(22,718,000)(13,774,000)(23,391,000)(24,600,000)
Loss before gain (loss) on sale of properties: (15,482,000)(29,203,000)(22,718,000)(13,774,000)(23,391,000)(24,600,000)
Net loss available to common stockholders, diluted: (15,482,000)(29,203,000)(22,718,000)(13,774,000)(23,391,000)(24,600,000)

Comprehensive Income (USD)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss: (15,482,000)(29,203,000)(22,718,000)(13,774,000)(23,391,000)(24,600,000)
Comprehensive loss: (15,482,000)(29,203,000)(22,718,000)(13,774,000)(23,391,000)(24,600,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (79,000)(18,000)(1,000)13,000(77,000)(35,000)
Comprehensive loss, net of tax, attributable to parent: (15,561,000)(29,221,000)(22,719,000)(13,761,000)(23,468,000)(24,635,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: